Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer

Published:2018-03-01 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Versteven Maarten,Van den Bergh Johan M. J.,Marcq Elly,Smits Evelien L. J.,Van Tendeloo Viggo F. I.,Hobo Willemijn,Lion Eva

Funder

Stichting Tegen Kanker

Fonds Wetenschappelijk Onderzoek

Agentschap Innoveren en Ondernemen

Bijzonder Onderzoeksfonds

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference164 articles.

1. Human dendritic cell subsets and function in health and disease;O’Keeffe;Cell Mol Life Sci,2015

2. NK cells: key to success of DC-based cancer vaccines?;Lion;Oncologist,2012

3. Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy;Van Acker;Oncoimmunology,2015

4. Directing dendritic cell immunotherapy towards successful cancer treatment;Sabado;Immunotherapy,2010

5. Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy;Rolinski;J Immunotoxicol,2014

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendritic cell-based immunotherapy in non-small cell lung cancer: a comprehensive critical review;Frontiers in Immunology;2024-09-06

2. A Dual Enhancing Strategy of Novel Nanovaccine Based on TIM3 Silencing Nanoadjuvants and Desialylated Cancer Cell Membrane Antigens for Personalized Vaccination Immunotherapy of Cancer;Advanced Functional Materials;2024-06-25

3. Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial;Nature Communications;2024-02-23

4. Navigating a Complex Intersection: Immunotherapy and Radiotherapy Synergy in Squamous Cell Carcinoma of the Skin—A Comprehensive Literature Review;Cosmetics;2023-12-04

5. Combining PD-1/PD-L1 blockade with type I interferon in cancer therapy;Frontiers in Immunology;2023-08-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3